Houston-based Texas Heart Institute received a grant to develop a first-in-class drug for cardiovascular disease and received $32 million from a patient.
Read the full post on Becker's Hospital Review - Healthcare News
Texas Heart Institute gets $32M from patient, $1.14M for drug development
